CAJ | 학술논문

目的:观察二黄扶正汤配合介入(肝动脉化疗栓塞治疗TACE)治疗发性肝癌的临床疗效.方法:将66例患者随机分为治疗组36例和对照组30例,两组均接受TACE,治疗组在TACE的基础上加服二黄扶正汤.两组均治疗3个月后观察中医临床证候改善情况、2年生存率及并发症情况.结果:临床证候改善率,治疗组为89%,对照组为50%,两组比较有显著性差异(P<0.01);2年生存率,治疗组为72%,对照组为37%,治疗组2年生存率明显高对照组(P<0.01);两组出现腹痛、呕吐或体温超过38℃的并发症情况,治疗组较对照组明显减少,两组比较差异有显著性(P<0.05).结论:发性肝癌在 TACE的基础上加服二黄扶正汤可明显改善患者的临床证候、减少并发症及提高患者2年生存率.
목적:관찰이황부정탕배합개입(간동맥화료전새치료TACE)치료발성간암적림상료효.방법:장66례환자수궤분위치료조36례화대조조30례,량조균접수TACE,치료조재TACE적기출상가복이황부정탕.량조균치료3개월후관찰중의림상증후개선정황、2년생존솔급병발증정황.결과:림상증후개선솔,치료조위89%,대조조위50%,량조비교유현저성차이(P<0.01);2년생존솔,치료조위72%,대조조위37%,치료조2년생존솔명현고대조조(P<0.01);량조출현복통、구토혹체온초과38℃적병발증정황,치료조교대조조명현감소,량조비교차이유현저성(P<0.05).결론:발성간암재 TACE적기출상가복이황부정탕가명현개선환자적림상증후、감소병발증급제고환자2년생존솔.
Objective:To investigate the clinical effect of Erhuang Fuzheng decoction combined with TACE on treating primary hepatic carcinoma. Methods:66 patients were randomly divided into two groups, 36 in the treated group and 30 in the control group. Both groups were given TACE, while the treated group was given Erhuang Fuzheng decoction more. Results: The total effective rates in the treated group and the control group were 89%and 50%respectively, with significant differences (P<0.01). The 2 year survival rates in the treated group and the control group were 72%and 37%respectively, with significant differences (P<0.01). The complications in the treated group was much lower than those in the control group (P<0.05). Conclusion: Erhuang Fuzheng decoction combined with TACE was significantly effective on treating primary hepatic carcinoma.